Рет қаралды 4,315
In this session, Hanno Ronte, Life Sciences & Healthcare industry leader, Deloitte Monitor and the panel members discussed about the shift in balance of power between pharma, payers, patients and other stakeholders shift in the next few years. They also discussed on how new drugs should be brought to market.